Abstract
The problem of catalyst-controlled site-selectivity can potentially require a catalyst to overcome energetic barriers larger than those associated with enantioselective reactions. This challenge is a signature of substrates that present reactive sites that are not of equivalent reactivity. Herein we present a narrative of our laboratory’s efforts to overcome this challenge using peptide-based catalysts. We highlight the interplay between understanding the inherent reactivity preferences of a given target molecule and the development of catalysts that can overcome intrinsic preferences embedded within a substrate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Matsumoto M, Lee SJ, Gagne MR, Waters ML (2014) Cross-strand histidine-aromatic interactions enhance acyl-transfer rates in beta-hairpin peptide catalysts. Org Biomol Chem 12:8711–8718
Matsumoto M, Lee SJ, Waters ML, Gagne MR (2014) A catalyst selection protocol that identifies biomimetic motifs from β-hairpin libraries. J Am Chem Soc 136:15817–15820
Julia S, Masana J, Vega JC (1980) “Synthetic enzymes”. Highly stereoselective epoxidation of a chalcone in a triphasic toluene-water-poly[(S)-alanine] system. Angew Chem Int Ed 19:929–931
Porter MJ, Roberts SM, Skidmore J (1999) Polyamino acids as catalysts in asymmetric synthesis. Bioorg Med Chem 7:2145–2156
Jarvo ER, Miller SJ (2002) Amino acids and peptides as asymmetric organocatalysts. Tetrahedron 58:2481–2495
Miller SJ (2004) In search of peptide-based catalysts for asymmetric organic synthesis. Acc Chem Res 37:601–610
Colby Davie EA, Mennen SM, Xu Y, Miller SJ (2007) Asymmetric catalysis mediated by synthetic peptides. Chem Rev 107:5759–5812
Wenemers H (2011) Asymmetric catalysis with peptides. Chem Commun 47:12036–12041
Lewandowski B, Wennemers H (2014) Asymmetric catalysis with short-chain peptides. Curr Opin Chem Biol 22:40–46
Kagan HB, Fiaud JC (1979) New approaches in asymmetric synthesis. In: Eliel EL, Allinger NL (eds) Topics in stereochemistry, vol 10. Wiley, Hoboken, pp 175–285
Kagan HB, Fiaud JC (1988) Kinetic resolution. In: Eliel EL, Wilen SH (eds) Topics in stereochemistry, vol 18. Wiley, Hoboken, pp 249–330
Fenwick DR, Kagan HB (1999) Asymmetric amplification. In: Denmark SE (ed) Topics in stereochemistry, vol 122. Wiley, Hoboken, pp 257–296
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298:1912–1934
Krebs EG (1983) Historical perspectives on protein phosphorylation and a classification system for protein kinases. Philos Trans R Soc Lond B Biol Sci 302:3–11
Demchenko AV (ed) (2008) Handbook of chemical glycosylation: advances in stereoselectivity and therapeutic relevance. Wiley-VCH, Weinheim
Ernst B, Hart GW, Sinay P (2000) Protecting groups: effects on reactivity, glycosylation stereoselectivity, and coupling efficiency. In: Green LG, Ley SV (eds) Carbohydrates in chemistry and biology. Wiley-VCH, Weinheim
Fischer E (1914) Über Phosphorsäureester des Methyl-glucosids und Theophyllin-glucosids. Ber Chem 47:3193–3205
Moffatt JG, Khorana HG (1957) Carbodiimides. VII. Tetra-p-nitrophenyl pyrophosphate, a new phosphorylating agent. J Am Chem Soc 79:3741–3746
Chambers RW, Moffatt JG, Khorana HG (1957) Nucleoside polyphosphates. IV. A new synthesis of guanosine-5′-phosphate. J Am Chem Soc 79:3747
Sculimbrene BR, Miller SJ (2001) Discovery of a catalytic asymmetric phosphorylation through selection of a minimal kinase mimic: a concise total synthesis of D-myo-inositol-1-phosphate. J Am Chem Soc 123:10125–10126
Sculimbrene BR, Morgan AJ, Miller SJ (2002) Enantiodivergence in small-molecule catalysis of asymmetric phosphorylation: concise total syntheses of the enantiomeric D-myo-inositol-1-phosphate and D-myo-inositol-3-phosphate. J Am Chem Soc 124:11653–11656
Sculimbrene BR, Morgan AJ, Miller SJ (2003) Nonenzymatic peptide-based catalytic asymmetric phosphorylation of inositol derivatives. Chem Commun 1781–1785
Agranoff BW, Fisher SK (1991) Inositol phosphates and derivatives: synthesis, biochemistry, and therapeutic potential. In Reitz AB (ed) ACS Symposium series 463, American Chemical Society, Washington, p 20
Billington DC (1993) The inositol phosphates: chemical synthesis and biological significance. VCH, New York
Pirrung MC (1999) Histidine kinases and two-component signal transduction systems. Chem Biol 121:11638–11643
Kee JM, Muir TW (2012) Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family. ACS Chem Biol 7:44–51
Copeland GT, Miller SJ (2001) Selection of enantioselective acyl transfer catalysts from a pooled peptide library through a fluorescence-based activity assay: an approach to kinetic resolution of secondary alcohols of broad structural scope. J Am Chem Soc 123:6496–6502
Jarvo ER, Copeland GT, Papaioannou N, Bonitatebus PJ, Miller SJ (1999) A biomimetic approach to asymmetric acyl transfer catalysis. J Am Chem Soc 121:11638–11643
Billington DC, Baker R, Kulagowski JJ, Mawer IM, Vacca JP, deSolms SJ, Huff JR (1989) The total synthesis of myo-inositol phosphates via myo-inositol orthoformate. J Chem Soc Perkin Trans 1:1423–1429
Irvine RF, Schell MJ (2001) Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2:327–338
Prestwich GD (2004) Phosphoinositide signaling: from affinity probes to pharmaceutical targets. Chem Biol 11:619–637
Di Paolo G, de Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657
Sculimbrene BR, Xu Y, Miller SJ (2004) Asymmetric syntheses of phosphatidylinositol-3-phosphates with saturated and unsaturated side chains through catalytic asymmetric phosphorylation. J Am Chem Soc 126:13182–13183
Morgan AJ, Wang YK, Roberts MF, Miller SJ (2004) Chemistry and biology of deoxy-myo-inositol phosphates: stereospecificity of substrate interactions within an archaeal and a bacterial IMPase. J Am Chem Soc 126:15370–15371
Morgan AJ, Komiya S, Xu Y, Miller SJ (2006) Unified total syntheses of the inositol polyphosphates: D-I-3,5,6P3, D-I-3,4,5P3, and D-I-3,4,5,6P4 via catalytic enantioselective and site-selective phosphorylation. J Org Chem 71:6923–6931
Xu Y, Sculimbrene BR, Miller SJ (2006) Streamlined synthesis of phosphatidylinositol (PI), PI3P, PI3,5P2, and deoxygenated analogues as potential biological probes. J Org Chem 71:4919–4928
Longo CM, Wei Y, Roberts MF, Miller SJ (2009) Asymmetric syntheses of L, L- and L, D-di-myo-inositol-1,1′-phosphate and their behavior as stabilizers of enzyme activity at extreme temperatures. Angew Chem Int Ed 48:4158–4161
Cuilla R, Burrgraf S, Stetter KO, Roberts MF (1994) Occurrence and role of di-myo-inositol-1,1′-phosphate in Methanococcus igneus. Appl Environ Microbiol 60:3660–3664
Chen L, Spiliotis ET, Roberts MF (1998) Biosynthesis of di-myo-inositol-1,1′-phosphate, a novel osmolyte in hyperthermophilic Archaea. J Bacteriol 180:3785–3792
Chandler BD, Burkhardt AL, Foley K, Cullis C, Driscoll D, D’Amore NR, Miller SJ (2014) A fully synthetic and biochemically validated phosphatidyl inositol-3-phosphate hapten via asymmetric synthesis and native chemical ligation. J Am Chem Soc 136:412–418
Harris JR, Markl J (1999) Keyhole limpet hemocyanin (KLH): a biomedical review. Micron 6:597–623
Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor, New York, Chapter 5
Hermanson GT (2008) Bioconjugate techniques, 2nd edn. Academic, New York, Chapter 19
Martin SF, Josey JA, Wong YL, Dean DW (1994) General method for the synthesis of phospholipid derivatives of 1,2-O-diacyl-sn-glycerols. J Org Chem 59:4805–4820
Dawson PE, Muir TW, Clark-Lewis I, Kent SBH (1994) Synthesis of proteins by native chemical ligation. Science 266:776–779
Johnson ECB, Kent SBH (2006) Insights into the mechanism and catalysis of the native chemical ligation reaction. J Am Chem Soc 128:6640–6646
Nilsson BL, Soellner MB, Raines RT (2005) Chemical synthesis of proteins. Annu Rev Biophys Biomol Struct 34:91–118
Fang GM, Cui HK, Zheng JS, Liu L (2010) Chemoselective ligation of peptide phenyl esters with N-terminal cysteines. ChemBioChem 11:1061–1065
Lewis CA, Sculimbrene BR, Xu Y, Miller SJ (2005) Desymmetrization of glycerol derivatives with peptide-based acylation catalysts. Org Lett 7:3021–3023
Griswold KS, Miller SJ (2003) A peptide-based catalyst approach to regioselective functionalization of carbohydrates. Tetrahedron 59:8869–8875
Evans JW, Fierman MB, Miller SJ, Ellman JA (2004) Catalytic enantioselective synthesis of sulfinate esters through the dynamic resolution of tert-butanesulfinyl chloride. J Am Chem Soc 126:8134–8135
Schreiber SL, Schreiber TS, Smith DB (1987) Reactions that proceed with a combination of enantiotopic group and diastereotopic face selectivity can deliver products with very high enantiomeric excess: experimental support of a mathematical model. J Am Chem Soc 109:1525–1529
Kawabata T, Nagato M, Takasu K, Fuji K (1997) Nonenzymatic kinetic resolution of racemic alcohols through an “induced fit” process. J Am Chem Soc 119:3169–3170
Kawabata T, Yamamoto K, Momose Y, Yoshida H, Nagaoka Y, Fuji K (2001) Kinetic resolution of amino alcohol derivatives with a chiral nucleophilic catalyst: access to enantiopure cyclic cis-amino alcohols. Chem Commun 2700–2701
Kawabata T, Muramatsu W, Nishio T, Shibata T, Schedel H (2007) A catalytic one-step process for the chemo- and regioselective acylation of monosaccharides. J Am Chem Soc 129:12890–12895
Ueda Y, Muramatsu W, Mishiro K, Furuta T, Kawabata T (2009) Functional group tolerance in organocatalytic regioselective acylation of carbohydrates. J Org Chem 74:8802–8805
Williamson CL, Chan L, Taylor MS (2012) Regioselective, borinic acid-catalyzed monoacylation, sulfonylation, and alkylation of diols and carbohydrates: expansion of substrate and mechanistic studies. J Am Chem Soc 134:8260–8267
Taylor MS (2015) Catalysis based on reversible covalent interactions of organoboron compounds. Acc Chem Res 48:295–305
Sun X, Lee H, Lee S, Tan KL (2013) Catalyst recognition of cis-1,2-diols enables site-selective functionalization of complex molecules. Nat Chem 5:790–795
Manville N, Alite H, Haeffner F, Hoveyda AH, Snapper ML (2013) Enantioselective silyl protection of alcohols promoted by a combination of chiral and achiral Lewis basic catalysts. Nat Chem 5:768–774
Blaisdell TP, Lee S, Kasaplar P, Sun X, Tan KL (2013) Practical silyl protection of ribonucleosides. Org Lett 15:4710–4713
Sun X, Worthy AD, Tan KL (2013) Resolution of terminal 1,2-diols via silyl transfer. J Org Chem 78:10494–10499
Sun X, Lee H, Lee S, Tan KL (2013) Catalyst recognition of cis-1,2-diols enables site-selective functionalization of complex molecules. Nature Chem 5:790–795
Zhao Y, Rodrigo J, Hoveyda AH, Snapper ML (2006) Enantioselective silyl protection of alcohols catalysed by amino-acid-based small molecule. Nature 443:64–70
Rawlings BJ (1999) Biosynthesis of polyketides (other than actinomycete macrolides). Nat Prod Rep 16:425–484
Shen B (2000) Biosynthesis of aromatic polyketides. Top Curr Chem 209:1–51
Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461–477
Walsh CT (2008) The chemical versatility of natural product assembly lines. Acc Chem Res 41:4–10
Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830:3670–3695
Hertweck C (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int Ed 48:4688–4716
Schetter B, Mahrwald R (2006) Modern aldol methods for the total synthesis of polyketides. Angew Chem Int Ed 45:7506–7525
Dechert-Schmitt AMR, Schmitt DC, Gao X, Itoh T, Krische MJ (2014) Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations. Reinventing the chemistry of carbonyl addition. Nat Prod Rep 31:504–513
Dalby SM, Paterson I (2010) Synthesis of polyketide natural products and analogs as promising anticancer agents. Curr Opin Drug Discov Devel 13:777–794
Cane DE, Walsh CT, Khosla C (1998) Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 282:63–68
Khosla C, Herschlag D, Cane DE, Walsh CT (2014) Assembly line polyketide synthases: mechanistic insights and unsolved problems. Biochemistry 53:2875–2883
Hutchinson CR, Fuji I (1995) Polyketide synthase gene manipulation: a structure-function approach in engineering novel antibiotics. Annu Rev Microbiol 49:201–238
Jacobsen JR, Hutchinson CR, Cane DE, Khosla C (1997) Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science 277:367–369
Hertweck C (2015) Decoding and reprogramming complex polyketide assemblylines: prospects for synthetic biology. Trends Biochem Sci 40:189–199
Wiley PF, Gerzon K, Flynn EH, Sigal MV, Weaver O, Quarck UC, Chauvette RR, Monahan R (1957) Erythromycin. X. Structure of erythromycin. J Am Chem Soc 79:6062–6070
Kim JW, Adachi H, Kazuo SY, Hayakwa Y, Seto H (1997) Apoptolidin, a new apoptosis inducer in transformed cells from Nocardiopsis sp. J Antibiot 50:628–630
Taylor RE, Chen Y, Galvin GM, Prabba PK (2004) Conformation-activity relationships in polyketide natural products. Towards to biologically active conformation of epothilone. Org Biomol Chem 2:127–132
Larsen EM, Wilson MR, Taylor RE (2015) Conformation-activity relationships of polyketide natural products. Nat Prod Rep 32:1183–1206
Wright GD (2005) Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 57:1451–1470
Walsh CT (2005) Molecular mechanisms that confer antibacterial drug resistance. Nature 406:775–781
Peddibhotia S, Dang Y, Liu JO, Romo D (2007) Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics. J Am Chem Soc 129:12222–12231
Robles O, Romo D (2014) Chemo- and site-selective derivatizations of natural products enabling biological studies. Nat Prod Rep 31:318–334
Lewis CA, Miller SJ (2006) Site-selective derivatization and remodeling of erythromycin A by using simple peptide-based chiral catalysts. Angew Chem Int Ed 45:5616–5619
Lewis CA, Merkel J, Miller SJ (2008) Catalytic site-selective synthesis and evaluation of a series of erythromycin analogs. Bioorg Med Chem Lett 18:6007–6011
Jones PH, Perun TJ, Rowley EK, Baker EJ (1972) Chemical modifications of erythromycin antibiotics. 3. Synthesis of 4″ and 11 esters of erythromycin A and B. J Med Chem 15:631–634
Martin YC, Jones PH, Perun TJ, Grundy WE, Bell S, Bower RR, Shipkowitz NL (1972) Chemical modification of erythromycin antibiotics. 4. Structure-activity relations of erythromycin esters. J Med Chem 15:635–638
Haque TS, Little JC, Gellman SH (1994) ‘Mirror image’ reverse turns promote β-hairpin formation. J Am Chem Soc 116:4105–4106
Haque TS, Little JC, Gellman SH (1996) Stereochemical requirements for β-hairpin formation: model studies with four-residue peptides and depsipeptides. J Am Chem Soc 118:6975–6985
Gellman SH (1998) Minimal models systems for β-sheet secondary structure in proteins. Curr Opin Chem Biol 2:717–725
Davies JS, Everett JR, Hatton IK, Hunt E, Tyler JW, Zomaya II, Slawin AMZ, Williams DJ (1991) NMR spectroscopic and X-ray crystallographic studies on the structure, stereochemistry and conformation of a series of 9,11 cyclic aminals of (9S)-9-N-methylerythromyclamine A. J Chem Soc Perkin Trans 2:201–214
Everett JR, Hunt E, Tyler JW (1991) Ketone-hemiacetal tautomerism in erythromycin A in non-aqueous solutions. An NMR spectroscopic study. J Chem Soc Perkin Trans 2:1481–1487
Tardrew PL, Mao JCH, Kenney D (1969) Antibacterial activity of 2′esters of erythromycin. Appl Microbiol 18:159–165
Lewis CA, Longcore KE, Miller SJ, Wender PA (2009) An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts. J Nat Prod 72:1864–1869
Wender PA, Gulledge AV, Jankowski OD, Seto H (2002) Isoapoptolidin: structure and activity of the ring-expanded isomer of apoptolidin. Org Lett 4:3819–3822
Pennington JD, Williams HJ, Salomon AR, Sulikowski GA (2002) Toward a stable apoptolidin derivative: identification of isoapoptolidin and selective deglycosylation of apoptolidin. Org Lett 4:3823–3825
Wender PA, Jankowski OD, Longcore K, Tabet EA, Seto H, Tomikawa T (2006) Correlation of F0F1-ATPase inhibition and antiproliferative activity of apoptolidin analogues. Org Lett 8:589–592
Linnane P, Magnus N, Magnus P (1997) Induction of molecular asymmetry by a remote chiral group. Nature 385:799–801
Clayden J, Lund A, Vallverdu L, Helliwell M (2004) Ultra-remote stereocontrol by conformational communication of information along a carbon chain. Nature 431:966–971
Byrne L, Sola J, Boddaert T, Marcelli T, Adams RW, Morris GA, Clayden J (2014) Foldamer-mediated remote stereocontrol: >1,60 asymmetric induction. Angew Chem Int Ed 53:151–155
Lewis CA, Chiu A, Kubryk M, Balsells J, Pollard D, Esser CK, Murry J, Reamer RA, Hansen KB, Miller SJ (2006) Remote desymmetrization at near-nanometer group separation catalyzed by a miniaturized enzyme mimic. J Am Chem Soc 128:16454–16455
Lewis CA, Gustafson JL, Chiu A, Balsells J, Pollard D, Murry J, Reamer RA, Hansen KB, Miller SJ (2008) A case of remote asymmetric induction in the peptide-catalyzed desymmetrization of a bis(phenol). J Am Chem Soc 130:16358–16455
Hoveyda A, Evans DA, Fu GC (1993) Substrate-directable chemical reactions. Chem Rev 93:1307–1370
Yoshimoto FK, Guengerich FP (2014) Mechanism of the third oxidative step in the conversion of androgens to estrogens by cytochrome P450 19A1 steroid aromatase. J Am Chem Soc 136:15016–15025
Pallan PS, Nagy LD, Li L, Gonzalez E, Kramlinger VM, Azumaya CM, Waterman MR, Guengerich FP, Egli M, Wawrzak Z (2015) Structural and kinetic basis of steroid 17α,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A2. J Biol Chem 290:3248–3268
Payne AH, Hales DB (2004) Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 25:947–970
Barton DHR, McCombie SW (1975) A new method for the deoxygenation of secondary alcohols. J Chem Soc Perkin Trans 1:1574–1585
Barton DHR, Blundell P, Dorchak J, Jang DO, Jaszberenyi J (1991) The invention of radical reactions. Part XXI. Simple methods for the radical deoxygenation of primary alcohols. Tetrahedron 47:8969–8984
Barton DHR, Dorchak J, Jaszberenyi J (1992) The invention of radical reactions. Part XXIV. Relative rates of acylation and radical deoxygenation of secondary alcohols. Tetrahedron 48:7435–7446
Sanchez-Rosello M, Puchlopek ALA, Morgan AJ, Miller SJ (2008) Site-selective catalysis of phenyl thionoformate transfer as a tool for regioselective deoxygenation of polyols. J Org Chem 73:1774–1782
Jordan PA, Kayser-Bricker KJ, Miller SJ (2010) Asymmetric phosphorylation through catalytic P(III) phosphoramidite transfer: enantioselective synthesis of D-myo-inositol-6-phosphate. Proc Natl Acad Sci U S A 107:20620–20624
Sculimbrene BR (2004). Catalytic asymmetric phosphorylation. Ph.D. thesis. Boston College, Boston
Carruthers MH (1991) Chemical synthesis of DNA and DNA analogs. Acc Chem Res 24:278–284
Vlasuk GP, Webb TR, Abelman MM, Pearson DA, Miller TA (21, 1999) US Patent 5492895
Hayakawa Y, Katoka M (1997) Preparation of short oligonucleotides via the phosphoramidite method using a tetrazole promoter in a catalytic manner. J Am Chem Soc 119:11758–11762
Jordan PA, Miller SJ (2012) An approach to the site-selective deoxygenation of hydroxyl groups based on catalytic phosphoramidite transfer. Angew Chem Int Ed 51:2907–2911
Zhang L, Koreeda M (2004) Radical deoxygenation of hydroxyl groups via phosphites. J Am Chem Soc 126:13190–13191
Fiori KW, Puchlopek ALA, Miller SJ (2009) Enantioselective sulfonylation reactions mediated by a tetrapeptide catalyst. Nat Chem 1:630–634
Butler MS, Hansford KA, Blaskovich MAT, Halai R, Cooper MA (2014) Glycopeptide antibiotics: back to the future. J Antibiot 67:631–644
Hubbard BK, Walsh CT (2003) Vancomycin assembly: nature’s way. Angew Chem Int Ed 42:730–765
Nicolaou KC, Boddy CNC, Brase S, Winissinger N (1999) Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew Chem Int Ed 38:2097–2152
Williams DH (1996) The glycopeptide story – how to kill the deadly ‘superbugs.’. Nat Prod Rep 13:469–477
Min G, Chen Z, Onishi HR, Kohler J, Silver LL, Kerns R, Fukuzawa S, Thompson C, Kahne D (1999) Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science 284:507–511
Kerns R, Dong SD, Fukuzawa S, Carbeck J, Kohler J, Silver LL, Kahne D (2000) The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics. J Am Chem Soc 122:12608–12609
Sun B, Chen Z, Eggert US, Shaw SJ, LaTour JV, Kahne D (2001) Hybrid glycopeptide antibiotics. J Am Chem Soc 123:12722–12723
Lin H, Walsh CT (2004) A chemoenzymatic approach to glycopeptide antibiotics. J Am Chem Soc 126:13998–14003
Leimkuhler C, Chen L, Barrett D, Panzone G, Sun B, Falcone B, Oberthuer M, Walker S, Kahne D (2005) Differential inhibition of Staphylococcus aureus PBP2 by glycopeptide antibiotics. J Am Chem Soc 127:3250–3251
Ashford PA, Bew SP (2012) Recent advances in the synthesis of new glycopeptide antibiotics. Chem Soc Rev 41:957–978
Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE et al (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49:1127–1134
Zhanel GC, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagace-Wiens PRS, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA (2010) New lipoglycopeptides: a comparative review of dalbavancin, oritavancin, and telavancin. Drugs 70:859–886
Reynolds PE (1989) Structure, biochemistry, and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8:943–950
Mackay JP, Gerhard U, Beauregard DA, Williams DH, Westwell MS, Searle MS (1994) Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J Am Chem Soc 116:4581–4590
Dong SD, Oberthuer M, Losey HC, Anderson JW, Eggert US, Peczuh MW, Walsh CT, Kahne D (2002) The structural basis for induction of VanB resistance. J Am Chem Soc 124:9064–9065
McComas CC, Crowley BM, Boger DL (2003) Partitioning the loss in vancomycin binding affinity or D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions. J Am Chem Soc 125:9314–9315
Crowley BM, Boger DL (2006) Total synthesis and evaluation of [Ψ[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 128:2885–2892
Xie J, Pierce JG, James RC, Okano A, Boger DL (2011) A redesigned vancomycin engineered for dual D-Ala-D-Ala and D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria. J Am Chem Soc 133:13946–13949
Xie J, Okano A, Pierce JG, James RC, Stamm S, Crane CM, Boger DL (2012) Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding. J Am Chem Soc 134:1284–1297
Bugg TDH, Wright GD, Dutka-Malen S, Arthur M, Courvalin P, Walsh CT (1991) Molecular basis for vancomycin resistance in Enterococus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30:10408–10415
Walsh CT, Fisher SL, Park IS, Prahalad M, Wu Z (1996) Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem Biol 3:21–28
Walsh CT (1993) Vancomycin resistance: decoding the molecular logic. Science 261:308–309
Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, Burke MD (2012) Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A 109:2234–2239
Hanessian S, Giguere A, Grzyb J, Maianti JP, Saavedra OM, Aggen JB, Linsell MS, Goldblum AA, Hildebrandt DJ, Kane TR, Dozzo P, Gliedt MJ, Matias RD, Feeney LA, Armstrong ES (2011) Toward overcoming Staphylococcus aureus aminoglycoside resistance mechanism with a functionally designed neomycin analogue. ACS Med Chem Lett 2:924–928
Szpilman AM, Cereghetti DM, Manthorpe JM, Wurtz NR, Carreira EM (2009) Synthesis and biophysical studies on 35-deoxy amphotericin B methyl ester. Chem Eur J 15:7117–7128
Fujisawa KL, Hoshiya T, Kawaguchi H (1974) Aminoglycoside antiobiotics. VII. Acute toxicity of aminoglycoside antibiotics. J Antibiot 27:677–681
Griffith BR, Krepel C, Fu X, Blanchard S, Ahmed A, Edmiston CE, Thorson JS (2007) Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE. J Am Chem Soc 129:8150–8155
Thompson C, Ge M, Kahne D (1999) Synthesis of vancomycin from the aglycon. J Am Chem Soc 121:1237–1244
Fowler BS, Lammerhold KM, Miller SJ (2012) Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxy-dependent conformational effects. J Am Chem Soc 134:9755–9761
Yoganathan S, Miller SJ (2015) Structure diversificiation of vancomycin through peptide-catalyzed, site-selective lipidation: a catalysis-based approach to combat glycopeptide-resistant pathogens. J Med Chem 58:2367–2377
Fowler BS, Mikochik PJ, Miller SJ (2010) Peptide-catalyzed kinetic resolution of formamides and thioformamides as an entry to nonracemic amines. J Am Chem Soc 132:2870–2871
Han S, Miller SJ (2013) Asymmetric catalysis at a distance: catalytic, site-selective phosphorylation of teicoplanin. J Am Chem Soc 135:12414–12421
Han S, Le BV, Hajare HS, Baxter RHG, Miller SJ (2014) X-Ray crystal structure of teicoplanin-A2-2 bound to a catalytic peptide sequence via the carrier protein strategy. J Org Chem 79:8550–8556
Chan HC, Huang YT, Lyu SY, Huang CJ, Li YS, Liu YC, Chou CC, Tsai MD, Li TL (2011) Regioselective deacetylation based on teicoplanin-complexed Orf2* crystal structures. Mol Biosyst 7:1224–1231
Nieto M, Perkins HR (1971) The specificity of combination between ristocetins and peptides related to bacterial cell-wall mucopeptide precursors. Biochem J 124:845–852
Economou NJ, Zentner IJ, Lazo E, Jakonicic J, Stojanoff V, Weeks SD, Gratsky KC, Cocklin S, Loll PJ (2013) Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach. Acta Crystallogr D69:520–533
Economou NJ, Nahoum V, Weeks SD, Gratsky KC, Zentner IJ, Townsend TM, Bhuiya MW, Cocklin S, Loll PJ (2012) A carrier protein strategy yields the structure of dalbavancin. J Am Chem Soc 134:4637–4645
Muir TW, Sondhi D, Cole PA (1998) Expressed protein ligation: a general method for protein engineering. Proc Natl Acad Sci U S A 95:6705–6710
Muir TW (2013) Semisynthesis of proteins by expressed protein ligation. Annu Rev Biochem 72:249–289
Gustafson J, Lim D, Miller SJ (2010) Dynamic kinetic resolution of biaryl atropisomers via peptide-catalyzed asymmetric bromination. Science 328:1251–1255
Garand E, Kamrath MZ, Jordan PA, Wolk AB, McCoy AB, Miller SJ (2012) Determination of non-covalent docking by IR spectroscopy of cold gas-phase complexes. Science 335:694–698
Barrett KT, Miller SJ (2013) Enantioselective synthesis of atropisomeric benzamides through peptide-catalyzed bromination. J Am Chem Soc 135:2963–2966
Barrett KT, Metrano AJ, Rablen PR, Miller SJ (2014) Spontaneous transfer of chirality in an atropisomerically enriched two-axis system. Nature 509:71–75
Denmark SE, Burk MT (2010) Lewis base catalysis of bromo- and iodolactonization and cycloetherification. Proc Natl Acad Sci U S A 107:20655–20660
Pathak TP, Miller SJ (2012) Site-selective bromination of vancomycin. J Am Chem Soc 134:6120–6123
Pathak TP, Miller SJ (2013) Chemical tailoring of teicoplanin with site-selective reactions. J Am Chem Soc 135:8415–8422
Fu X, Tan CH (2011) Mechanistic considerations of guanidine-catalyzed reactions. Chem Commun 47:8210–8222
Anderson KW, Buchwald SL (2005) General catalysts for the Suzuki-Miyaura and Songoashira coupling reactions of aryl chlorides and for the coupling of challenging substrate combinations in water. Angew Chem Int Ed 44:6173–6177
Van Temelen EE, Heys JR (1975) Enzymic epoxidation of squalene variants. J Am Chem Soc 97:1252–1253
Maayan G, Ward MD, Kirshenbaum K (2009) Folded biomimetic oligomers for enantioselective catalysis. Proc Natl Acad Sci U S A 106:13679–13684
Berkessel A, Koch B, Toniolo C, Rainaldi M, Broxterman QB, Kaptein B (2006) Asymmetric enone epoxidation by short solid-phase bound peptides: further evidence for catalyst helicity and catalytic activity of individual peptide strands. Biopolymers 84:90–96
Formagio F, Boncio M, Crisma M, Peggion C, Mezzato S, Polese A, Barazza A, Antonello S, Maran F, Broxterman QB, Kaptein B, Kamphuis J, Vitale RM, Saviano M, Benedetti E, Toniolo C (2002) Nitroxyl peptides as catalysts of enantioselective oxidations. Chem Eur J 8:84–93
Peris G, Jakobsche CE, Miller SJ (2007) Aspartate-catalyzed asymmetric epoxidation reactions. J Am Chem Soc 129:8710–8711
Jakobsche CE, Peris G, Miller SJ (2008) Functional analysis of an aspartate-based epoxidation catalyst with amide-to-alkene peptidomimetic catalyst analogues. Angew Chem Int Ed 120:6809–6813
Kolundzic F, Noshi MN, Tjandra M, Movassaghi M, Miller SJ (2011) Chemoselective and enantioselective oxidation of indoles employing aspartyl peptide catalysts. J Am Chem Soc 133:9104–9111
Mercado-Marin EV, Garcia-Reynaga P, Romminger S, Pimenta EF, Romney DK, Lodewyk MW, Williams DE, Andersen RJ, Miller SJ, Tantillo DJ, Berlinck RGS, Sarpong R (2014) Total synthesis and isolation of citrinalin and cyclopiamine congeners. Nature 509:293–294
Gnanadesikan V, Corey EJ (2008) A strategy for position-selective epoxidation of polyprenols. J Am Chem Soc 130:8089–8093
Chang S, Lee NH, Jacobsen EN (1993) Regio- and enantioselective catalytic epoxidation of conjugated polyenes. Formal synthesis of LTA4 methyl ester. J Org Chem 58:6939–6941
Burke CP, Shi Y (2006) Regio- and enantioselective epoxidation of dienes by a chiral dioxirane: synthesis of optically active vinyl cis-epoxides. Angew Chem Int Ed 45:4475–4478
Barlan AU, Baak A, Yamamoto H (2006) Enantioselective oxidation of olefins catalyzed by a chiral bishydroxamic acid complex of molybdenum. Angew Chem Int Ed 45:5849–5852
Lichtor PA, Miller SJ (2012) Combinatorial evolution of site- and enantioselective catalysts for polyene epoxidation. Nat Chem 4:990–995
Lichtor PA, Miller SJ (2014) Experimental lineage and functional analysis of a remotely directed peptide epoxidation catalyst. J Am Chem Soc 136:5301–5308
Abascal NC, Lichtor PA, Giuliano MW, Miller SJ (2014) Function-oriented investigations of a peptide-based catalyst that mediates enantioselective allylic alcohol epoxidation. Chem Sci 5:4504–4511
Lichtor PA, Miller SJ (2011) One-bead-one-catalyst approach to aspartic acid-based oxidation catalyst discovery. ACS Comb Sci 13:321–326
Brustad EM, Arnold FH (2011) Optimizing non-natural protein function with directed evolution. Curr Opin Chem Biol 15:201–210
Foo K, Usui I, Gotz DCG, Werner EW, Holte D, Baran PS (2012) Scalable, enantioselective synthesis of germacrenes and related sesquiterpenes inspired by terpene cyclase phase logic. Angew Chem Int Ed 51:11491–11495
Yoon TP, Jacobsen EN (2003) Privileged chiral catalysts. Science 299:1691–1693
Breslow R, Gellman SH (1983) Intramolecular nitrene C-H insertions mediated by transition-metal complexes as nitrogen analogues of cytochrome P-450 reactions. J Am Chem Soc 105:6729–6730
Breslow R, Gellman SH (1982) Tosylamidation of cyclohexane by a cytochrome P-450 model. J Chem Soc Chem Commun 1400–1401
Breslow R (1980) Biomimetic control of chemical selectivity. Acc Chem Res 13:170–177
Xu D, Crispino GA, Sharpless KB (1992) Selective asymmetric dihydroxylation (AD) of dienes. J Am Chem Soc 114:7570–7571
Becker H, Soler MA, Sharpless KB (1995) Selective asymmetric dhihydroxylation of polyenes. Tetrahedron 51:1345–1376
Kolb HC, VanNieuwenhze MS, Sharpless KB (1994) Catalytic asymmetric dihydroxylation. Chem Rev 94:2483–2547
Jacobsen EN, Pfaltz A, Yamamoto H (eds) (1999) Comprehensive asymmetric catalysis, vol I–III and Supplement 1. Springer, New York
Chen MS, White MC (2007) A predictably selective aliphatic C-H oxidation reaction for complex molecule synthesis. Science 318:783–787
Newhouse T, Baran PS (2011) If C-H bonds could talk: selective C-H bond oxidation. Angew Chem Int Ed 50:3362–3374
Vohidov F, Coughlin JM, Ball ZT (2015) Rhodium(II) metallopeptie catalyst design enables fine control in selective functionalization of natural SH3 domains. Angew Chem Int Ed 54:4587–4591
Ball ZT (2012) Designing enzyme-like catalysts: a rhodium(II) metallopeptide case study. Acc Chem Res 46:560–570
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Giuliano, M.W., Miller, S.J. (2015). Site-Selective Reactions with Peptide-Based Catalysts. In: Kawabata, T. (eds) Site-Selective Catalysis. Topics in Current Chemistry, vol 372. Springer, Cham. https://doi.org/10.1007/128_2015_653
Download citation
DOI: https://doi.org/10.1007/128_2015_653
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26331-1
Online ISBN: 978-3-319-26333-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)